Julie Rubinstein

Companies

• Adaptive BiotechnologiesChief operating officer Mar 6, 2025 to now¹
• Adaptive BiotechnologiesPresident Jun 26, 2019 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABAdaptive Biotechnologies ADPT377,802 shares³$9.1M at $24.01Apr 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 27, 2026Sold 19,037 shares at $14.23 of Adaptive Biotechnologies³
• Apr 27, 2026Exercised options 14,707 shares at $8.46 of Adaptive Biotechnologies³
• Apr 24, 2026Sold 19,060 shares at $14.02 of Adaptive Biotechnologies⁴
• Apr 24, 2026Exercised options 14,722 shares at $8.46 of Adaptive Biotechnologies⁴
• Apr 23, 2026Sold 19,060 shares at $13.74 of Adaptive Biotechnologies⁴
• Apr 23, 2026Exercised options 14,722 shares at $8.46 of Adaptive Biotechnologies⁴
• Apr 22, 2026Sold 19,060 shares at $14.13 of Adaptive Biotechnologies⁴
• Apr 22, 2026Exercised options 14,722 shares at $8.46 of Adaptive Biotechnologies⁴
• Apr 21, 2026Sold 30,941 shares at $14.66 of Adaptive Biotechnologies⁵
• Apr 21, 2026Exercised options 11,881 shares at $12.14 of Adaptive Biotechnologies⁵
• Apr 21, 2026Exercised options 14,722 shares at $8.46 of Adaptive Biotechnologies⁵
• Apr 20, 2026Sold 19,060 shares at $14.55 of Adaptive Biotechnologies⁵
• Apr 20, 2026Exercised options 14,722 shares at $8.46 of Adaptive Biotechnologies⁵
• Apr 17, 2026Sold 19,060 shares at $14.57 of Adaptive Biotechnologies⁵
• Apr 17, 2026Exercised options 14,722 shares at $8.46 of Adaptive Biotechnologies⁵
• Apr 16, 2026Sold 19,060 shares at $14.18 of Adaptive Biotechnologies⁶
• Apr 16, 2026Exercised options 14,722 shares at $8.46 of Adaptive Biotechnologies⁶
• Apr 15, 2026Sold 19,060 shares at $14.61 of Adaptive Biotechnologies⁶
• Apr 15, 2026Exercised options 14,722 shares at $8.46 of Adaptive Biotechnologies⁶
• Apr 14, 2026Sold 19,060 shares at $14.56 of Adaptive Biotechnologies⁶
• Apr 14, 2026Exercised options 14,722 shares at $8.46 of Adaptive Biotechnologies⁶
• Apr 13, 2026Sold 3,338 shares at $14.08 of Adaptive Biotechnologies⁷
• Apr 13, 2026Sold 15,722 shares at $12.95 of Adaptive Biotechnologies⁷
• Apr 13, 2026Exercised options 6,613 shares at $8.46 of Adaptive Biotechnologies⁷
• Apr 13, 2026Exercised options 8,109 shares at $7.27 of Adaptive Biotechnologies⁷